[email protected]

国际医药研究前沿

International Medical Research Frontier

您当前位置:首页 > 精选文章

International Medical Research Frontier. 2025; 9: (2) ; 10.12208/j.imrf.20250019 .

Efficacy analysis of paroxetine hydrochloride combined with low dose quinoperidone in treating depression with insomnia in the elderly
盐酸帕罗西汀联合小剂量喹硫平治疗老年抑郁症伴失眠的疗效分析

作者: 朱彩琴 *

上海市宝山区吴淞中心医院 上海

*通讯作者: 朱彩琴,单位:上海市宝山区吴淞中心医院 上海;

引用本文: 朱彩琴 盐酸帕罗西汀联合小剂量喹硫平治疗老年抑郁症伴失眠的疗效分析[J]. 国际医药研究前沿, 2025; 9: (2) : 49-51.
Published: 2025/6/25 11:20:32

摘要

目的 本文旨在评估盐酸帕罗西汀与小剂量喹硫平联合用药方案对老年抑郁症并发失眠症状的干预效果。方法:对在我院接受治疗的抑郁症合并睡眠障碍老年患者分别给予盐酸帕罗西汀治疗(对照组)和盐酸帕罗西汀+小剂量喹硫平治疗(观察组),对比两组治疗效果。结果 观察组患者治疗效果、心理状态以及生活质量和睡眠质量评分均明显优于对照组,P<0.05,组间存在对比性,且两组间安全性指标未见统计学差异(P>0.05)。结论 研究证实该联合用药方案兼具确切疗效与良好耐受性,具有重要的临床实践意义和推广价值。

关键词: 老年抑郁症伴失眠;盐酸帕罗西汀;小剂量喹硫平;临床疗效

Abstract

Objective To evaluate the intervention effect of paroxetine hydrochloride combined with low-dose quetiapine on senile depression complicated with insomnia.
Methods the elderly patients with depression and sleep disorder in our hospital were given paroxetine hydrochloride treatment (control group) and paroxetine hydrochloride+small dose quetiapine treatment (observation group), respectively, and the therapeutic effects of the two groups were compared.
Results the treatment effect, psychological status, quality of life and sleep quality scores of the observation group were significantly better than those of the control group, P<0.05, There was contrast between the two groups, and there was no significant difference in safety indicators between the two groups (P>0.05).
Conclusion   the study confirmed that the combination regimen has both exact curative effect and good tolerance, which has important clinical significance and promotion value.

Key words: Senile depression with insomnia; Paroxetine hydrochloride; Low dose quetiapine; Clinical efficacy

参考文献 References

[1] 段芮,王红.2011-2018年我国中老年人抑郁症状流行趋势分析[J].预防医学,2023,35(8):649-654.

[2] 蔡启梅,王娟.共情反馈式心理护理联合放松训练在抑郁症患者中的应用效果[J].中国当代医药,2025,32(12):159-162.

[3] Wang J ,Bai L ,Bao Y, et al.Comparative efficacy and safety of different pharmacological interventions for the treatment of depression associated with insomnia in the elderly population: a systematic review and network meta-analysis.[J]. Psychogeriatrics: the official journal of the Japanese Psychogeriatric Society,2025,25(3):e70041.

[4] 中华医学会精神医学分会老年精神医学学组,于欣,王涛,等.老年期抑郁障碍诊疗专家共识(2025版)[J].中华精神科杂志,2025,58(08):592-602.

[5] 黄萍.个性化护理对抑郁症患者生活质量的影响[J].世界最新医学信息文摘(连续型电子期刊),2020,20(29):298,300.

[6] 袁娜华,童丽,曹江,等.睡眠护理对轻度抑郁症伴发睡眠障碍患者的干预效果[J].现代实用医学,2020,32(3):394-396. 

[7] 格根图雅.盐酸帕罗西汀治疗老年焦虑性抑郁症的疗效评价[J].中国处方药,2024,22(02):120-122.

[8] 莫夸耀.阿戈美拉汀、盐酸帕罗西汀治疗老年期抑郁症的有效性及对睡眠质量的影响[J].中外医学研究,2022, 20(32):22-25.

[9] 王静辉,孙晨,吕江玲.认知性心理护理在老年抑郁症患者中的应用效果[J].心理月刊,2024,19(19):132-134.

[10] Kerpershoek L M ,Giltay J E ,Kok L A A , et al.Six-year trajectories of core depressive symptoms and insomnia symptoms in depressed older adults: a NESDO study.[J]. Aging & mental health,2025,1-9.